83299-002 Wart Remover Ointment

Manufacturer
Consilii LLC
Effective date
2023-04-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:33:16

Label at a glance#

ProductWart Remover Ointment.
Active ingredientSALICYLIC ACID, CHLORHEXIDINE
Label structure14 sections

Dosage and administration

wash the affected area may soak the wart in warm water for 5minutes dry area thoroughly. using the applicator(cotton swab)apply a layer of ointment to sufficiently cover each wart aliow it to fully absorb and cover it witha bandage as needed repeat this procedure once or twicedaily as needed (until the wart isremoved) for up to 12 weeks

Storage and handling

Keep away from direct sunlight or heat. Store at room tempetature 15°-30°C (59°-86°F)

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 1%
Chlorhexidine di(acetate) 1%

Purpose

OTC - PURPOSE SECTION

Wart remover

Use

INDICATIONS & USAGE SECTION

for the removal of common and plantar warts
the common wart is easily recognizedby the rough "cauliflower-like'appearance of the surface.
the plantar wart is recognized by itslocation only on the bottom of the foot.its tendemess and the interruption of the footprint pattern

Warnings

WARNINGS SECTION

For external use only.
Keep away from fire and flame.

Do not use

OTC - DO NOT USE SECTION

if discomfort persists.
if you have diabetes or poor bioodcirculation

WHEN USING SECTION

OTC - WHEN USING SECTION

avoid contact with eyes lf the product gets into the eye, flush with water for 15
minutes
avoid inhaling vapors
cap the tube tightly
out of direct sunlight and store at room temperature away from heat

STOP USE section

OTC - STOP USE SECTION

if discomfort persists.
if you have diabetes or poor blood circulation.

ASK DOCTOR

OTC - ASK DOCTOR SECTION

if discomfort persists.
if you have diabetes or poor bioodcirculation

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

DOSAGE & ADMINISTRATION SECTION

wash the affected area
may soak the wart in warm water for 5minutes
dry area thoroughly.
using the applicator(cotton swab)apply a layer of ointment to sufficiently cover each wart
aliow it to fully absorb and cover it witha bandage as needed
repeat this procedure once or twicedaily as needed (until the wart isremoved) for up to 12 weeks

Other information

STORAGE AND HANDLING SECTION

Keep away from direct sunlight or heat.
Store at room tempetature 15°-30°C (59°-86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Fructus cnidii, radix sophorae
flavescentis, herba portulacae, rhizoma
atractyiodis macrocephalae, radix
angelicae dahuricae.

QUESTIONS

OTC - QUESTIONS SECTION

1-914-608-125

PACKAGE LABEL - PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

83299-002-01

83299-002-0183299-002-01

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
83299-002-012024-01-30C16284748780-11030e365-6d50-111a-e063-dadaa90a10e283299-002 Wart Remover Ointment

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83299-00283299-002-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
20d14d02-8332-9c30-e063-6394a90aedc1f8a800dc-082f-43a5-e053-6294a90a65482024-08-29WarningsExact identifier
spl set id: f8a800dc-082f-43a5-e053-6294a90a6548

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.